Article and Video CATEGORIES

Cancer Journey

Search By

SBRT for Oligometastatic Lung Cancer
Tue, 02/02/2016 - 06:00
Author
GRACE Videos and Articles
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, defines oligometastatic lung cancer and describes the recent trend toward the use of stereotactic body radiation therapy to treat it.

 

Download Transcript

 

Transcript

First, let’s define the term “oligometastatic disease.” Oligometastatic disease typically means patients who have metastatic disease, but have a few metastases that, if they could be eradicated, their life could be prolonged. There are some good examples of the literature where patients have been resected, let’s say for metastatic colorectal cancer, or metastatic renal cancer, let’s say they had a brain metastasis that was resected and given curative therapy for their primary cancer, and there is about a 20-25% overall survival rate in that situation.

That, broadened out with the development of stereotactic body radiation therapy, has brought into play SBRT for patients with oligometastases for a variety of tumors. There is some recent literature in lung cancer, let’s say, that show that if you have patients with a few metastases that are receiving systemic therapy, that you can achieve median survivals approaching 20 months in metastatic lung cancer, and that’s previously unseen. That data was a trial from UT Southwestern and the University of Colorado groups, published this past year in the JCO — one of the most cited papers in the JCO this past year.

I think the oligometastatic patient population is a good patient population for focused radiation therapy. People ask, “what is oligometastasis?” It has classically been defined as patients with three or fewer metastases who have their remainder of the disease or the disease burden is under control with  systemic therapy; some have expanded that to five or six metastases. It typically doesn’t matter where they are. The classic example, of course, is a metastasis to the brain. We’ve applied this to patients in the lung, liver, spine, various places that are able to receive this focused radiation dose, and I think it’s a good tool, if chosen for the right patients, to extend their survival — perhaps we could even cure a few.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Forum Discussions

n3p, Hi and welcome to Grace. I'm sorry you have to check for new nodules. It does sound like your onc has good reason not to be alarmed that you have...

Thanks for the thoughtful response, I really appreciate that! All your points make sense. I will check back in later.

Please do check back in. It looks like I forgot to paste in links for that article. I'm going back to edit in the links.

Hi blp2020, 


Welcome to Grace. I'm sorry you're having trouble. It would be very extremely rare to find a pancoast tumor in person your age. They are normally found in older...

Hi Sel87, Welcome to Grace.  I'm so terribly sorry that your mother is going through this.  I'm going to assume that there are no brain mets found, so let me know...

Sel87, thank you for reaching out to us. I hope that the link Janine sent to you was helpful. As you can imagine, many of the questions that we see here...

Recent Comments

JOIN THE CONVERSATION
Thank you Janine I…
By Cari on Tue, 01/31/2023 - 19:23
There are a lot of good…
By Cari on Tue, 01/31/2023 - 14:47
Scans
By Cari on Tue, 01/31/2023 - 12:41
Sel87, thank you for…
By Amy B on Tue, 01/31/2023 - 09:00